Medizinische Universität Innsbruck — Innsbruck

Public research footprint of Medizinische Universität Innsbruck, compiled from the ClinicalTrials.gov public registry.

164

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Familial Primary Pulmonary Hypertension · HER2-(Ultra)Low Expressing Breast Cancer · Moderately to Severely Active Ulcerative Colitis · Neovascular Age-related Macular Degeneration

Recently updated registry entries

NCT04053088 — SAVR: IMPACT of Pre-existing Comorbidities on Patient Outcomes and Prosthetic Valve… (Active Not Recruiting)
NCT06847542 — A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD (Recruiting)
NCT06819878 — A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Medizinische Universität Innsbruck?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.